Researchers in the United Kingdom will deliberately infect 90 healthy volunteers with COVID-19 to study the virus and potentially speed up development of a vaccine, a type of trial that Harvard investigators have said could ease the global death burden.
Researchers in the United Kingdom will deliberately infect 90 healthy volunteers with COVID-19 to study the virus and potentially speed up development of a vaccine, a type of trial that Harvard investigators have said could ease the global death burden. Imperial College London and a group of researchers said Tuesday that they are preparing a human challenge study, a type of research used infrequently because some question the ethics of infecting otherwise healthy individuals. “Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines,” wrote Dr.
